Return On Assets of NRX Pharmaceuticals, Inc. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
NRX Pharmaceuticals, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • NRX Pharmaceuticals, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -490%, a 1.5% increase year-over-year.
  • NRX Pharmaceuticals, Inc. annual Return On Assets for 2024 was -586%, a 201% decline from 2023.
  • NRX Pharmaceuticals, Inc. annual Return On Assets for 2023 was -194%, a 55% decline from 2022.
  • NRX Pharmaceuticals, Inc. annual Return On Assets for 2022 was -126%, a 65% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

NRX Pharmaceuticals, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -490% +8% +1.5% 01 Jul 2025 30 Sep 2025
Q2 2025 -658% -246% -60% 01 Apr 2025 30 Jun 2025
Q1 2025 -460% -177% -62% 01 Jan 2025 31 Mar 2025
Q4 2024 -586% -391% -201% 01 Oct 2024 31 Dec 2024
Q3 2024 -498% -346% -228% 01 Jul 2024 30 Sep 2024
Q2 2024 -412% -266% -183% 01 Apr 2024 30 Jun 2024
Q1 2024 -283% -162% -133% 01 Jan 2024 31 Mar 2024
Q4 2023 -194% -69% -55% 01 Oct 2023 31 Dec 2023
Q3 2023 -152% +28% +15% 01 Jul 2023 30 Sep 2023
Q2 2023 -146% +83% +36% 01 Apr 2023 30 Jun 2023
Q1 2023 -121% +110% +48% 01 Jan 2023 31 Mar 2023
Q4 2022 -126% +237% +65% 01 Oct 2022 31 Dec 2022
Q3 2022 -179% +413% +70% 01 Jul 2022 30 Sep 2022
Q2 2022 -228% +677% +75% 01 Apr 2022 30 Jun 2022
Q1 2022 -231% +1191% +84% 01 Jan 2022 31 Mar 2022
Q4 2021 -363% +599% +62% 01 Oct 2021 31 Dec 2021
Q3 2021 -592% -540% -1026% 01 Jul 2021 30 Sep 2021
Q2 2021 -905% -898% -13428% 01 Apr 2021 30 Jun 2021
Q1 2021 -1423% -1418% -33694% 01 Jan 2021 31 Mar 2021
Q4 2020 -962% -963% -115293% 01 Oct 2020 31 Dec 2020
Q3 2020 -53% -65% -537% 01 Jul 2020 30 Sep 2020
Q2 2020 -7% -17% -163% 01 Apr 2020 30 Jun 2020
Q1 2020 -4% -5% -1345% 01 Jan 2020 31 Mar 2020
Q4 2019 1% +1% +783% 01 Oct 2019 31 Dec 2019
Q3 2019 12% +22% 01 Jul 2019 30 Sep 2019
Q2 2019 11% 01 Apr 2019 30 Jun 2019
Q1 2019 0% 01 Jan 2019 31 Mar 2019
Q4 2018 0% 01 Oct 2018 31 Dec 2018
Q3 2018 -10% 01 Jul 2018 30 Sep 2018

NRX Pharmaceuticals, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -586% -391% -201% 01 Jan 2024 31 Dec 2024
2023 -194% -69% -55% 01 Jan 2023 31 Dec 2023
2022 -126% +237% +65% 01 Jan 2022 31 Dec 2022
2021 -363% +599% +62% 01 Jan 2021 31 Dec 2021
2020 -962% -963% -115293% 01 Jan 2020 31 Dec 2020
2019 1% +1% +783% 01 Jan 2019 31 Dec 2019
2018 0% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.